Gardedam Therapeutics could name its drug after you! (If you donate enough to its crowdfunding effort)
Palo Alto biotech Gardedam Therapeutics is taking the crowdfunding route to raise $195,000 funding for its Parkinson’s and Alzheimer’s disease drug candidate. And it’s offering up perks like personal lab tours in Cambridge or Budapest, or the opportunity to rename a lead drug candidate to the donors that pony up more than $50,000. Donors at the […]
